Inquirer Opinion on MSN1h
Game-changer for pharmaceuticals
Researchers from the University of the Philippines Manila recently developed a cost-effective painkiller made from an herbal ...
Based on interviews with Nick Rowe, innovation manager at Silver Fern Farms, chief executive and founder of Opo Bio, Dr ...
Two AI healthcare stocks -- Recursion Pharmaceuticals ( RXRX -2.76%) and Teladoc Health ( TDOC -5.20%) -- have lagged the ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
Consumers who purchased certain generic prescription drugs between May 2009 and December 2019 are eligible for compensation.
The Indian e-commerce industry is projected to reach US$ 325 billion by 2030, experiencing significant growth. * Third-party logistics providers are anticipated to manage approximately 17 billion ...
An editorial on how to cut health care costs stirred readers to offer solutions of their own, from pushing for a single-payer ...
U.S. President Donald Trump said on Friday that he was open to carving out deals with countries seeking to avoid U.S. tariffs ...
Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...
U.S. President Donald Trump indicated a willingness to negotiate tariff deals with other countries, contingent on reciprocal ...
With expertise in pharmaceutical supply chains and medical technology, healthcare CEO and entrepreneur Dr. Jay Bhaumik has ...
Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...